Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Escherichia coli (PSE-1 + penicillin-resistant) |
- |
- |
≤0.025 - ? |
LJC 11036 |
40 |
Escherichia coli (PSE-1 + penicillin-resistant) |
- |
- |
0.2 - ? |
Cefdinir (Omnicef, Cefdiel) |
40 |
Escherichia coli (PSE-1 + penicillin-resistant) |
- |
- |
0.2 - ? |
Imipenem |
40 |
Escherichia coli (PSE-1 + penicillin-resistant) |
- |
- |
0.39 - ? |
Faropenem |
40 |
Escherichia coli (PSE-1 + penicillin-resistant) |
- |
- |
0.39 - ? |
Levofloxacin (Levaquin, Quixin) |
40 |
Escherichia coli (PSE-3 + penicillin-resistant) |
- |
- |
≤0.025 - ? |
LJC 11036 |
40 |
Escherichia coli (PSE-3 + penicillin-resistant) |
- |
- |
0.2 - ? |
Cefdinir (Omnicef, Cefdiel) |
40 |
Escherichia coli (PSE-3 + penicillin-resistant) |
- |
- |
0.39 - ? |
Imipenem |
40 |
Escherichia coli (PSE-3 + penicillin-resistant) |
- |
- |
0.39 - ? |
Levofloxacin (Levaquin, Quixin) |
40 |
Escherichia coli (PSE-4) |
- |
- |
0.125 - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
187 |
Escherichia coli (quinolone-resistant) |
0.007 |
0.015 |
≤0.007 - 0.015 |
Meropenem (Merrem) |
1394 |
Escherichia coli (quinolone-resistant) |
0.03 |
0.125 |
≤0.007 - 1 |
Cefotaxime (Cephotaxime, Claforan) |
1394 |
Escherichia coli (quinolone-resistant) |
0.125 |
0.25 |
0.03 - 2 |
Cefditoren (Spectracef) |
1394 |
Escherichia coli (quinolone-resistant) |
0.5 |
0.5 |
0.125 - 16 |
Cefminox |
1394 |
Escherichia coli (quinolone-resistant) |
1 |
4 |
0.5 - 16 |
Cefuroxime (Kefurox, Zinacef) |
1394 |
Escherichia coli (quinolone-resistant) |
2 |
8 |
0.5 - 8 |
Piperacillin-Tazobactam (Zosyn) |
1394 |
Escherichia coli (quinolone-resistant) |
4 |
8 |
0.5 - 32 |
Amoxicillin-clavulanate |
1394 |
Escherichia coli (quinolone-resistant) |
32 |
64 |
4 - 128 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1394 |
Escherichia coli (quinolone-resistant) |
32 |
64 |
16 - 128 |
Levofloxacin (Levaquin, Quixin) |
3 |
Escherichia coli (quinolone-resistant) |
>128 |
>128 |
4 - 32 |
Trovafloxacin (Trovan) |
3 |
Escherichia coli (quinolone-resistant) |
>128 |
>128 |
32 - >128 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
3 |
Escherichia coli (quinolone-susceptible) |
0.008 |
0.03 |
0.008 - 0.03 |
Levofloxacin (Levaquin, Quixin) |
3 |
Escherichia coli (quinolone-susceptible) |
0.015 |
0.015 |
0.008 - 0.06 |
ABT-492 |
3 |
Escherichia coli (R477-100) |
- |
- |
0.02 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1118 |
Escherichia coli (R477-100) |
- |
- |
24 - ? |
Neopeptin B |
1118 |
Escherichia coli (R477-100) |
- |
- |
48 - ? |
Gentamicin C1A |
1005 |
Escherichia coli (R477-100) |
- |
- |
48 - ? |
NB45 |
1005 |
Escherichia coli (RAM121) |
- |
- |
2.9 - ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
794 |